Angel Yeast, a company specializing in enzyme preparations, plans to invest 370 million yuan in establishing a pilot-scale validation base for synthetic biology. This project is expected to be completed within 16 months. Separately, European space startup The Exploration Company is in discussions to raise at least $300 million, potentially valuing the company at over $2 billion, with the EU's 'European Exploration Fund' considering participation. AI
IMPACT Angel Yeast's synthetic biology investment could lead to new bio-based materials or processes, while The Exploration Company's funding advances space technology development.
RANK_REASON The cluster contains a significant investment in synthetic biology by Angel Yeast and a substantial funding round for a European space startup. [lever_c_demoted from significant: ic=1 ai=0.4]
- Angel Yeast
- Changxin Technology
- Demis Hassabis
- Enzyme Preparation Company
- EQT Partners
- European Commission
- European Exploration Fund
- The Exploration Company
- Trip.com Group
- UniGroup
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
